[e-drug] Out Patient Parenteral Antimicrobial Therapy (cont'd)

["Dr. Douglas Ball" <dball@hsc.kuniv.edu.kw>]

E-DRUG: Out Patient Parenteral Antimicrobial Therapy (cont'd)
--------------------------------------------------------------

> I will not want to encourage OPAT because it will lead to 
> indiscriminate injection use with the attendant risks in the 
> developing countries.

Jude Nwokike's warning about the differences in health systems and
health practices between industrialised countries and developing nations
is certainly relevant and one would need to consider what problems might
arise in each particular setting (and the resources required to manage
them). One must also bear in mind that the costs of health care also
differ considerably such that whilst OPAT may be shown to be
cost-effective in European countries, for example, it does not
automatically follow that it is cost-effective in an African country
scenario.

Regards

Douglas Ball

==========================
Dr. Douglas Ball PhD
Dept. of Pharmacy Practice
Faculty of Pharmacy, Health Sciences Center
University of Kuwait, PO Box 24923 Safat 13110
Kuwait
Tel: (965)531-2300 ext. 6048
Fax: (965)534-2807
E-mail: dball@hsc.kuniv.edu.kw 
--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug